Proteostasis Therapeutics Inc. (PTI)

5.07
Prev Close 5.07
Day Low/High 0.00 / 0.00
52 Wk Low/High 1.41 / 8.61
Avg Volume 2.17M
Exchange
Shares Outstanding 34.48M
Market Cap 175.17M
EPS -2.30
Div & Yield N.A. (N.A)

Latest News

Glancy Prongay & Murray LLP Announces Investigation On Behalf Of Proteostasis Therapeutics, Inc. Investors (PTI)

Glancy Prongay & Murray LLP Announces Investigation On Behalf Of Proteostasis Therapeutics, Inc. Investors (PTI)

Glancy Prongay & Murray LLP ("GPM") announces an investigation on behalf of Proteostasis Therapeutics, Inc.

Proteostasis Therapeutics Announces FDA Grants Breakthrough Therapy Designation For PTI-428 In Cystic Fibrosis

Proteostasis Therapeutics Announces FDA Grants Breakthrough Therapy Designation For PTI-428 In Cystic Fibrosis

Designation granted for PTI-428 for the treatment of CF patients based on the results from a recent Phase 2, randomized, placebo controlled study

That Wild Market Momentum Has Cooled

That Wild Market Momentum Has Cooled

But here are some movers I am looking at today.

Proteostasis Therapeutics Reports Preliminary Data From Phase 1 Study Of PTI-428 In Patients With Cystic Fibrosis

Proteostasis Therapeutics Reports Preliminary Data From Phase 1 Study Of PTI-428 In Patients With Cystic Fibrosis

Screening Initiated in Phase 2 Portion of PTI-428 Study, 28-day Dosing Cohort

Proteostasis Therapeutics Announces Clinical And Regulatory Progress Across Pipeline Programs

Updates Announced During the 40th European Cystic Fibrosis Society Conference

Oversold Conditions For Proteostasis Therapeutics (PTI)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: DISCK, FOR, FPI, IAG, TITN Downgrades: PATI, SCKT, TCRD, TRC, UBP Initiations: PTI Read on to get TheStreet Quant Ratings' detailed report:

TheStreet Quant Rating: D (Sell)